ANSWERS | PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains
Advanced Pharmacokinetics and Pharmacodynamics in Anesthesia
Advanced Physiology and Pathophysiology across the Lifespan
Airway Management and Advanced Respiratory Technology
Regional Anesthesia, Pain Management, and Local Anesthetics
Anesthetic Equipment, Monitoring, and Safety Standards
Professional Practice, Law, Ethics, and Quality Improvement
Special Populations, Obstetric, and Pediatric Anesthesia
Introduction
This comprehensive examination is designed to rigorously evaluate the advanced clinical
competency, critical reasoning, and applied knowledge of nurse anesthesia professionals
preparing for licensure and professional practice. The assessment measures advanced
proficiency across core pharmacological, physiological, technical, and safety domains
required for safe, independent, and evidence-based patient management in complex
surgical environments. Utilizing a balanced blend of direct multiple-choice inquiries and
complex scenario-based clinical problems, the test bank emphasizes real-world
application, rapid diagnostic decision-making, and risk mitigation. Candidates are tested on
,their ability to synthesize complex clinical data, adhere to strict regulatory standards, and
execute expert-level interventions under pressure.
Section One: Questions 1–100
Question 1
A 68-year-old male with severe aortic stenosis is scheduled for an urgent open laparotomy.
During induction, the patient develops profound systemic hypotension (blood pressure
65/35 mmHg) and bradycardia (heart rate 45 beats/min). Which of the following is the most
appropriate initial management step?
A. Immediate administration of intravenous nitroglycerin to reduce afterload
B. Prompt administration of an alpha-agonist such as phenylephrine along with an
anticholinergic
C. Initiation of high-dose sodium nitroprusside infusion for rapid afterload reduction
D. Immediate discontinuation of ventilation and initiation of chest compressions
🟢 B. Prompt administration of an alpha-agonist such as phenylephrine along with an
anticholinergic
🔴 Explanation: Severe aortic stenosis is characterized by a fixed left ventricular outflow
obstruction, rendering these patients critically dependent on maintaining systemic vascular
resistance (SVR) and sinus rhythm with an adequate preload. Hypotension reduces
coronary perfusion pressure, precipitating ischemia, ventricular failure, and arrest.
Phenylephrine restores SVR without significantly increasing heart rate, while an
anticholinergic addresses the bradycardia. Vasodilators like nitroglycerin or nitroprusside
,are absolutely contraindicated because they abolish SVR, leading to catastrophic
circulatory collapse.
Question 2
Which of the following neuromuscular blocking agents undergoes elimination primarily via
Hofmann elimination and ester hydrolysis, making it ideal for patients with severe hepatic
and renal dysfunction?
A. Vecuronium
B. Rocuronium
C. Cisatracurium
D. Pancuronium
🟢 C. Cisatracurium
🔴 Explanation: Cisatracurium is a benzylisoquinolinium nondepolarizing neuromuscular
blocker that undergoes degradation primarily via spontaneous non-enzymatic chemical
breakdown at normal body temperature and pH (Hofmann elimination), supplemented by
plasma esterase hydrolysis. Because its clearance is independent of hepatic metabolism
and renal excretion, its duration of action remains predictable in patients with multi-organ
failure. Vecuronium, rocuronium, and pancuronium rely heavily on biliary and renal
excretion pathways.
Question 3
A patient with a known history of malignant hyperthermia susceptibility is brought to the
operating room for an emergency appendectomy. Which of the following induction
, techniques is completely safe from triggering a malignant hyperthermia episode?
A. Propofol infusion, rocuronium, and nitrous oxide
B. Sevoflurane induction followed by succinylcholine administration
C. Desflurane maintenance with succinylcholine intubation conditions
D. Isoflurane anesthesia paired with high-flow oxygen delivery
🟢 A. Propofol infusion, rocuronium, and nitrous oxide
🔴 Explanation: Malignant hyperthermia (MH) is a pharmacogenetic hypermetabolic
disorder triggered by all volatile inhalation anesthetics (such as sevoflurane, desflurane,
and isoflurane) and the depolarizing muscle relaxant succinylcholine. Total intravenous
anesthesia using agents like propofol, opioids, and non-depolarizing neuromuscular
blockers like rocuronium or cisatracurium are entirely safe and do not trigger MH. Nitrous
oxide is also considered a non-triggering agent.
Question 4
During a routine general anesthetic, the end-tidal carbon dioxide (EtCO2) suddenly drops
from 38 mmHg to 10 mmHg accompanied by a precipitous decline in arterial blood
pressure and oxygen saturation. Which of the following is the most likely diagnosis?
A. Severe bronchospasm
B. Massive pulmonary embolism or air embolism
C. Malignant hyperthermia crisis
D. Sudden hyperventilation by the anesthesia provider
🟢 B. Massive pulmonary embolism or air embolism